Chimeric antigen receptor T-cell therapy for melanoma.
Azadehsadat RazaviMahsa Keshavarz-FathiJohn PawelekNima RezaeiPublished in: Expert review of clinical immunology (2021)
Despite obstacles and the risk of adverse events, CAR T cell therapy could be used for patients with treatment-resistant cancer. Clinical trials are underway to determine the efficacy of this approach for the treatment of melanoma.